Top compounds associated with response to NOL4L


Feature Type Standardized
Nominal ANOVA
mRNA AC220 GDSC1000 pan-cancer AAC 0.075 0.03
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.077 0.04
mRNA IOX2 GDSC1000 pan-cancer AAC -0.071 0.04
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.076 0.04
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.072 0.04
mRNA BRD-K71935468 CTRPv2 pan-cancer AAC -0.081 0.04
mRNA ETP-46464 CTRPv2 pan-cancer AAC -0.09 0.04
mRNA MS-275 GDSC1000 pan-cancer AAC 0.11 0.04
mRNA Parthenolide CTRPv2 pan-cancer AAC -0.08 0.04
mRNA Vinblastine GDSC1000 pan-cancer AAC -0.07 0.04
Download CSV